Small-Molecule Disruptors of the Interaction between Calcium- and Integrin-Binding Protein 1 and Integrin α


Journal

ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411

Informations de publication

Date de publication:
12 Jul 2024
Historique:
received: 19 01 2024
revised: 09 05 2024
accepted: 14 05 2024
pmc-release: 29 05 2025
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 18 7 2024
Statut: epublish

Résumé

Thrombosis, a key factor in most cardiovascular diseases, is a major contributor to human mortality. Existing antithrombotic agents carry a risk of bleeding. Consequently, there is a keen interest in discovering innovative antithrombotic agents that can prevent thrombosis without negatively impacting hemostasis. Platelets play crucial roles in both hemostasis and thrombosis. We have previously characterized calcium- and integrin-binding protein 1 (CIB1) as a key regulatory molecule that regulates platelet function. CIB1 interacts with several platelet proteins including integrin α

Identifiants

pubmed: 39022362
doi: 10.1021/acsptsci.4c00026
pmc: PMC11249646
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1971-1982

Informations de copyright

© 2024 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Auteurs

Kalyan Golla (K)

Cardeza Center for Hemostasis, Thrombosis, and Vascular Biology, Cardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.

Adam Yasgar (A)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.

Voddarahally N Manjuprasanna (VN)

Cardeza Center for Hemostasis, Thrombosis, and Vascular Biology, Cardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.

Meghna U Naik (MU)

Cardeza Center for Hemostasis, Thrombosis, and Vascular Biology, Cardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.

Bolormaa Baljinnyam (B)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.

Alexey V Zakharov (AV)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.

Sankalp Jain (S)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.

Ganesha Rai (G)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.

Ajit Jadhav (A)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.

Anton Simeonov (A)

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.

Ulhas P Naik (UP)

Cardeza Center for Hemostasis, Thrombosis, and Vascular Biology, Cardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.

Classifications MeSH